ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

When Is Prophylactic Neck Dissection in Papillary Thyroid Cancer Necessary?

by Vikas Mehta, MD, and Cherie-Ann Nathan, MD • March 9, 2015

  • Tweet
  • Email
Print-Friendly Version

Trio Best Practice

You Might Also Like

  • Significant Number of Patients with Papillary Thyroid Carcinoma Will Have Macroscopic Nodal Disease
  • What Is the Treatment of the Lateral Neck in Clinically Localized Sporadic Medullary Thyroid Cancer?
  • What is the Appropriate Extent of Lateral Neck Dissection in the Treatment of Metastatic WDTC?
  • Management Issues in Recurrent and Metastatic Thyroid Cancer
Explore This Issue
March 2015

Background

The American Cancer Society estimates that there will be approximately 56,460 new diagnoses of thyroid cancer in the United States during 2012, and more than 90% will be papillary thyroid cancer (PTC). Despite the large, ever-increasing number of thyroid cancer cases, the ideal initial management of well-differentiated PTC remains controversial. The role of the prophylactic central neck dissection (pCND) has emerged as the most highly debated topic, with conflicting reports regarding indications, recurrence prevention, and reduction of cause-specific mortality. Currently, there is no argument that a formal, compartmental CND should be performed if pre-operative or palpable nodal disease is encountered. However, the 2009 American Thyroid Association (ATA) guidelines state that pCND may be performed in patients with PTC with clinically uninvolved central neck lymph nodes, especially for advanced primary tumors. With the advent of personalized therapy based on molecular testing, the BRAF gene has shown the most promise in predicting lymph node metastases and may be used to direct clinicians on whether to perform a pCND.

Best Practice

Based on large, population studies, one can infer that the presence of metastatic lymph nodes in patients with PTC does predict poorer survival for patients  > 45. The results of the meta-analysis mentioned above suggest that the use of pCND for all PTC patients is not warranted since the risks of transient nerve paralysis and hypoparathyroidism may outweigh the benefits. While the true advantage of prophylactic CND for PTC with regard to recurrence prevention and improved survival may be impossible to ascertain, the presence of metastatic lymph nodes should be investigated for staging and post-operative treatment planning in high-risk patients.

The questions then arise: 1) Which patients are high-risk for central neck metastases? 2) In which patients will the presence of nodal disease dictate treatment? In general all patients with pathologically confirmed PTC should undergo a pre-operative investigation for metastatic lymphadenopathy. However, the thyroid can obstruct the ultrasonographic view of the central compartment. Therefore, the 2009 ATA guidelines suggest that pCND may be performed in patients with clinically-staged T3/4 PTC disease, tumor size > 4cm, or presence of extrathyroidal extension, which has been confirmed as risk factors for occult lymph node metastases in other studies. The presence of a BRAF mutation, detected preoperatively on FNA, confers a 2.8-fold increase in the risk for occult central compartment metastases. Hence, the use of molecular testing for BRAF may further improve the ability to identify patients in need of a prophylactic central neck dissection. Finally, due to the overall excellent prognosis seen with PTC, prophylactic CND is a procedure with potential for increased iatrogenic harm and questionable benefit, implying that a surgeon’s comfort level with the procedure should also be taken into consideration. Read the full article in The Laryngoscope.

Pages: 1 2 | Single Page

Filed Under: Departments, Head and Neck, Head and Neck, Practice Focus, TRIO Best Practices Tagged With: central neck dissection, papillary thyroid cancerIssue: March 2015

You Might Also Like:

  • Significant Number of Patients with Papillary Thyroid Carcinoma Will Have Macroscopic Nodal Disease
  • What Is the Treatment of the Lateral Neck in Clinically Localized Sporadic Medullary Thyroid Cancer?
  • What is the Appropriate Extent of Lateral Neck Dissection in the Treatment of Metastatic WDTC?
  • Management Issues in Recurrent and Metastatic Thyroid Cancer

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Why Virtual Grand Rounds May Be Here to Stay
    • Otolaryngologist Leverages His Love of Pinball into Second Business
    • These New Imaging Advances May Help to Protect Parathyroids
    • Is the Training and Cost of a Fellowship Worth It? Here’s What Otolaryngologists Say
    • Which Otologic Procedures Poses the Greatest Risk of Aerosol Generation?

Polls

Have you used 3D-printed materials in your otolaryngology practice?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.